BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pekkanen-Mattila M, Kerkelä E, Tanskanen JM, Pietilä M, Pelto-Huikko M, Hyttinen J, Skottman H, Suuronen R, Aalto-Setälä K. Substantial variation in the cardiac differentiation of human embryonic stem cell lines derived and propagated under the same conditions--a comparison of multiple cell lines. Ann Med. 2009;41:360-370. [PMID: 19165643 DOI: 10.1080/07853890802609542] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Abdelwahid E, Siminiak T, Guarita-Souza LC, Teixeira de Carvalho KA, Gallo P, Shim W, Condorelli G. Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications. Curr Cardiol Rev. 2011;7:201-212. [PMID: 22758618 DOI: 10.2174/157340311798220502] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
2 Liu J, Zhang Z, Liu Y, Guo C, Gong Y, Yang S, Ma M, Li Z, Gao WQ, He Z. Generation, characterization, and potential therapeutic applications of cardiomyocytes from various stem cells. Stem Cells Dev 2012;21:2095-110. [PMID: 22428725 DOI: 10.1089/scd.2012.0031] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
3 Pradhapan P, Kuusela J, Viik J, Aalto-Setälä K, Hyttinen J. Cardiomyocyte MEA data analysis (CardioMDA)--a novel field potential data analysis software for pluripotent stem cell derived cardiomyocytes. PLoS One 2013;8:e73637. [PMID: 24069215 DOI: 10.1371/journal.pone.0073637] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
4 Ivashchenko CY, Pipes GC, Lozinskaya IM, Lin Z, Xiaoping X, Needle S, Grygielko ET, Hu E, Toomey JR, Lepore JJ. Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype. Am J Physiol Heart Circ Physiol. 2013;305:H913-H922. [PMID: 23832699 DOI: 10.1152/ajpheart.00819.2012] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 12.9] [Reference Citation Analysis]
5 Pringle S, De Bari C, Dell'Accio F, Przyborski S, Cooke MJ, Minger SL, Grigoriadis AE. Mesenchymal differentiation propensity of a human embryonic stem cell line. Cell Prolif 2011;44:120-7. [PMID: 21401753 DOI: 10.1111/j.1365-2184.2011.00744.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
6 Ikonen L, Kerkelä E, Metselaar G, Stuart MC, de Jong MR, Aalto-Setälä K. 2D and 3D self-assembling nanofiber hydrogels for cardiomyocyte culture. Biomed Res Int. 2013;2013:285678. [PMID: 23573513 DOI: 10.1155/2013/285678] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
7 Synnergren J, Heins N, Brolén G, Eriksson G, Lindahl A, Hyllner J, Olsson B, Sartipy P, Björquist P. Transcriptional profiling of human embryonic stem cells differentiating to definitive and primitive endoderm and further toward the hepatic lineage. Stem Cells Dev 2010;19:961-78. [PMID: 19757991 DOI: 10.1089/scd.2009.0220] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kuusela J, Kujala VJ, Kiviaho A, Ojala M, Swan H, Kontula K, Aalto-Setälä K. Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes. Springerplus 2016;5:234. [PMID: 27026928 DOI: 10.1186/s40064-016-1889-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
9 Robertson C, Tran DD, George SC. Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes. Stem Cells. 2013;31:829-837. [PMID: 23355363 DOI: 10.1002/stem.1331] [Cited by in Crossref: 222] [Cited by in F6Publishing: 192] [Article Influence: 31.7] [Reference Citation Analysis]
10 Xu C. Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells. J Mol Cell Cardiol. 2012;52:1203-1212. [PMID: 22484618 DOI: 10.1016/j.yjmcc.2012.03.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ting S, Lecina M, Chan YC, Tse HF, Reuveny S, Oh SK. Nutrient supplemented serum-free medium increases cardiomyogenesis efficiency of human pluripotent stem cells. World J Stem Cells 2013;5:86-97. [PMID: 23904910 DOI: 10.4252/wjsc.v5.i3.86] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
12 Pekkanen-Mattila M, Chapman H, Kerkelä E, Suuronen R, Skottman H, Koivisto AP, Aalto-Setälä K. Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype. Exp Biol Med (Maywood). 2010;235:522-530. [PMID: 20407085 DOI: 10.1258/ebm.2010.009345] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
13 Blazeski A, Zhu R, Hunter DW, Weinberg SH, Boheler KR, Zambidis ET, Tung L. Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells. Prog Biophys Mol Biol. 2012;110:178-195. [PMID: 22958937 DOI: 10.1016/j.pbiomolbio.2012.07.012] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
14 Blazeski A, Zhu R, Hunter DW, Weinberg SH, Zambidis ET, Tung L. Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility. Prog Biophys Mol Biol. 2012;110:166-177. [PMID: 22971665 DOI: 10.1016/j.pbiomolbio.2012.07.013] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
15 Nagvenkar P, Pethe P, Pawani H, Telang J, Kumar N, Hinduja I, Zaveri K, Bhartiya D. Evaluating differentiation propensity of in-house derived human embryonic stem cell lines KIND-1 and KIND-2. In Vitro Cell Dev Biol Anim 2011;47:406-19. [PMID: 21614653 DOI: 10.1007/s11626-011-9420-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
16 Abou-Saleh H, Zouein FA, El-Yazbi A, Sanoudou D, Raynaud C, Rao C, Pintus G, Dehaini H, Eid AH. The march of pluripotent stem cells in cardiovascular regenerative medicine. Stem Cell Res Ther 2018;9:201. [PMID: 30053890 DOI: 10.1186/s13287-018-0947-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
17 Mehta A, Chung YY, Ng A, Iskandar F, Atan S, Wei H, Dusting G, Sun W, Wong P, Shim W. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells. Cardiovascular Research 2011;91:577-86. [DOI: 10.1093/cvr/cvr132] [Cited by in Crossref: 77] [Cited by in F6Publishing: 56] [Article Influence: 7.7] [Reference Citation Analysis]
18 Rajala K, Lindroos B, Hussein SM, Lappalainen RS, Pekkanen-Mattila M, Inzunza J, Rozell B, Miettinen S, Narkilahti S, Kerkelä E, Aalto-Setälä K, Otonkoski T, Suuronen R, Hovatta O, Skottman H. A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. PLoS One 2010;5:e10246. [PMID: 20419109 DOI: 10.1371/journal.pone.0010246] [Cited by in Crossref: 114] [Cited by in F6Publishing: 95] [Article Influence: 10.4] [Reference Citation Analysis]
19 de Carvalho KA, Abdelwahid E, Ferreira RJ, Irioda AC, Guarita-Souza LC. Preclinical stem cell therapy in Chagas Disease: Perspectives for future research. World J Transplant 2013;3:119-26. [PMID: 24392316 DOI: 10.5500/wjt.v3.i4.119] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Riolobos L, Hirata RK, Turtle CJ, Wang PR, Gornalusse GG, Zavajlevski M, Riddell SR, Russell DW. HLA engineering of human pluripotent stem cells. Mol Ther 2013;21:1232-41. [PMID: 23629003 DOI: 10.1038/mt.2013.59] [Cited by in Crossref: 143] [Cited by in F6Publishing: 117] [Article Influence: 17.9] [Reference Citation Analysis]
21 Melkoumian Z, Weber JL, Weber DM, Fadeev AG, Zhou Y, Dolley-Sonneville P, Yang J, Qiu L, Priest CA, Shogbon C, Martin AW, Nelson J, West P, Beltzer JP, Pal S, Brandenberger R. Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol. 2010;28:606-610. [PMID: 20512120 DOI: 10.1038/nbt.1629] [Cited by in Crossref: 334] [Cited by in F6Publishing: 274] [Article Influence: 30.4] [Reference Citation Analysis]
22 Prajapati C, Ojala M, Lappi H, Aalto-Setälä K, Pekkanen-Mattila M. Electrophysiological evaluation of human induced pluripotent stem cell-derived cardiomyocytes obtained by different methods. Stem Cell Res 2021;51:102176. [PMID: 33485184 DOI: 10.1016/j.scr.2021.102176] [Reference Citation Analysis]
23 Pekkanen-Mattila M, Pelto-Huikko M, Kujala V, Suuronen R, Skottman H, Aalto-Setälä K, Kerkelä E. Spatial and temporal expression pattern of germ layer markers during human embryonic stem cell differentiation in embryoid bodies. Histochem Cell Biol 2010;133:595-606. [PMID: 20369364 DOI: 10.1007/s00418-010-0689-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
24 Renner H, Becker KJ, Kagermeier TE, Grabos M, Eliat F, Günther P, Schöler HR, Bruder JM. Cell-Type-Specific High Throughput Toxicity Testing in Human Midbrain Organoids. Front Mol Neurosci 2021;14:715054. [PMID: 34335182 DOI: 10.3389/fnmol.2021.715054] [Reference Citation Analysis]
25 Mehta A, Verma V, Nandihalli M, Ramachandra CJ, Sequiera GL, Sudibyo Y, Chung Y, Sun W, Shim W. A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells. PLoS One 2014;9:e103485. [PMID: 25068310 DOI: 10.1371/journal.pone.0103485] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
26 Kim YY, Ku JB, Liu HC, Ku SY, Kim SH, Choi YM. Ginsenosides may enhance the functionality of human embryonic stem cell-derived cardiomyocytes in vitro. Reprod Sci 2014;21:1312-8. [PMID: 24615935 DOI: 10.1177/1933719114525269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
27 Rungarunlert S, Klincumhom N, Tharasanit T, Techakumphu M, Pirity MK, Dinnyes A. Slow turning lateral vessel bioreactor improves embryoid body formation and cardiogenic differentiation of mouse embryonic stem cells. Cell Reprogram 2013;15:443-58. [PMID: 24020697 DOI: 10.1089/cell.2012.0082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
28 Mandenius C, Steel D, Noor F, Meyer T, Heinzle E, Asp J, Arain S, Kraushaar U, Bremer S, Class R, Sartipy P. Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review: Cardiotoxicity testing using derived stem cells. J Appl Toxicol 2011;31:191-205. [DOI: 10.1002/jat.1663] [Cited by in Crossref: 62] [Cited by in F6Publishing: 44] [Article Influence: 6.2] [Reference Citation Analysis]
29 Wobus AM, Löser P. Present state and future perspectives of using pluripotent stem cells in toxicology research. Arch Toxicol 2011;85:79-117. [PMID: 21225242 DOI: 10.1007/s00204-010-0641-6] [Cited by in Crossref: 105] [Cited by in F6Publishing: 74] [Article Influence: 10.5] [Reference Citation Analysis]
30 Stefanova VT, Grifo JA, Hansis C. Derivation of novel genetically diverse human embryonic stem cell lines. Stem Cells Dev 2012;21:1559-70. [PMID: 22204497 DOI: 10.1089/scd.2011.0642] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
31 Paci M, Sartiani L, Del Lungo M, Jaconi M, Mugelli A, Cerbai E, Severi S. Mathematical modelling of the action potential of human embryonic stem cell derived cardiomyocytes. Biomed Eng Online 2012;11:61. [PMID: 22929020 DOI: 10.1186/1475-925X-11-61] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
32 Viitanen J, Heimala P, Hokkanen A, Iljin K, Kerkelä E, Kolari K, Kattelus H. Stimulation of human embryonic stem cell-derived cardiomyocytes on thin-film microelectrodes. Biotechnology Journal 2011;6:600-3. [DOI: 10.1002/biot.201000355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Kreutzer J, Ikonen L, Hirvonen J, Pekkanen-mattila M, Aalto-setälä K, Kallio P. Pneumatic cell stretching system for cardiac differentiation and culture. Medical Engineering & Physics 2014;36:496-501. [DOI: 10.1016/j.medengphy.2013.09.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
34 Karabekian Z, Ding H, Stybayeva G, Ivanova I, Muselimyan N, Haque A, Toma I, Posnack NG, Revzin A, Leitenberg D, Laflamme MA, Sarvazyan N. HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications. Tissue Eng Part A 2015;21:2559-71. [PMID: 26218149 DOI: 10.1089/ten.TEA.2015.0105] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
35 Ojala M, Rajala K, Pekkanen-Mattila M, Miettinen M, Huhtala H, Aalto-Setälä K. Culture conditions affect cardiac differentiation potential of human pluripotent stem cells. PLoS One 2012;7:e48659. [PMID: 23119085 DOI: 10.1371/journal.pone.0048659] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
36 Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan X, Peters A, Mahairaki V, Koliatsos VE, Tung L, Zambidis ET. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One. 2011;6:e18293. [PMID: 21494607 DOI: 10.1371/journal.pone.0018293] [Cited by in Crossref: 286] [Cited by in F6Publishing: 253] [Article Influence: 28.6] [Reference Citation Analysis]
37 Pekkanen-Mattila M, Ojala M, Kerkelä E, Rajala K, Skottman H, Aalto-Setälä K. The effect of human and mouse fibroblast feeder cells on cardiac differentiation of human pluripotent stem cells. Stem Cells Int 2012;2012:875059. [PMID: 22315618 DOI: 10.1155/2012/875059] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
38 Sala L, Bellin M, Mummery CL. Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come? Br J Pharmacol 2017;174:3749-65. [PMID: 27641943 DOI: 10.1111/bph.13577] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 14.6] [Reference Citation Analysis]
39 Kaufman DS. Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. Blood. 2009;114:3513-3523. [PMID: 19652198 DOI: 10.1182/blood-2009-03-191304] [Cited by in Crossref: 114] [Cited by in F6Publishing: 100] [Article Influence: 9.5] [Reference Citation Analysis]
40 Ryynänen T, Kujala V, Ylä-outinen L, Korhonen I, Tanskanen JM, Kauppinen P, Aalto-setälä K, Hyttinen J, Kerkelä E, Narkilahti S, Lekkala J. All Titanium Microelectrode Array for Field Potential Measurements from Neurons and Cardiomyocytes—A Feasibility Study. Micromachines 2011;2:394-409. [DOI: 10.3390/mi2040394] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]